Business · 18/04/2000Updated: 10/17/2026 · 1 min read
FDA Approves New Animal Drug for Intramammary Infusion
The FDA is updating its regulations to reflect the approval of a new animal drug, Cephapirin Sodium, for intramammary infusion, following a supplemental application from Fort Dodge Animal Health.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →